Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Adaptive Biotech, NeoGenomics, Biological Dynamics, More

Adaptive Biotechnologies: Tycho Peterson

Tycho Peterson has been appointed as CFO of Adaptive Biotechnologies. He joins the company after 23 years at JP Morgan Chase, where he was most recently managing director of life science tools and diagnostics in the healthcare group. He holds an MSc/MBA degree in biology and business administration from the University of Oxford and a BS in biology from Cornell University.

NeoGenomics: George Cardoza, Steven Brodie, David Sholehvar

George Cardoza, president and chief operating officer of laboratory operations for NeoGenomics, is retiring from both positions, effective March 31. Steven Brodie, currently senior vice president of laboratory operations at NeoGenomics, has been appointed interim president of lab operations at the firm.

Additionally, David Sholehvar was appointed president of the clinical services division of the company, effective March 14. Before joining NeoGenomics, he was CEO of Dynex Technologies. Before that, he was VP of Quest Diagnostics' largest sales region, as well as GM of infectious disease and immunology. He also was VP for the Americas and Europe, Middle East, and Africa for Johnson & Johnson Ortho Clinical Diagnostics.

Biological Dynamics: Paul Billings

Paul Billings has returned as CEO of Biological Dynamics, after having served as chief medical officer and senior vice president of medical affairs at Natera. Before departing for Natera, Billings had previously served as adviser, director, and board chairman at Biological Dynamics. Billings has also worked as chief medical officer at Laboratory Corporation of America Holdings and Life Technologies, and has served on the US Food and Drug Administration's Scientific Advisory Board, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and as an appointee to the Secretary's Advisory Committee on Genetics, Health, and Society at the Department of Health and Human Services.

For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.